Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.

T Papp; M Jafari; U Diener; N Dudley; D Schiffmann

doi:10.1101/gr.3.2.125

ARTICLE

Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.

- Institute of Toxicology, University of Würzburg, Germany.

Published October 1, 1993. Vol 3 Issue 2, pp. 125-126. https://doi.org/10.1101/gr.3.2.125

Cite Article Permissions

Current Issue:

April 2026, Vol. 36, No. 4

This article requires a subscription/paid access. Click here for options on how to access the full text.

Purchase short term access

Buy access to this article online for 24 hours. This includes access to:

The HTML version on the journal website, along with any supplementary material
A PDF version that can be downloaded for offline use during or after the access period

Access via an Institutional Subscription

You may already have access via your institution. Connect securely to your campus network or connect via an institutional VPN to see whether you have access.

Recommend this journal to your institution

If you do not have subscription access and would like to recommend this journal to your librarian, please use this online form.

Focus view

Article contents

Article (Back to top)
- References

ARTICLE

Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.

Cite this article

Share

Current Issue:

Purchase short term access

Access via an Institutional Subscription

Recommend this journal to your institution

Article contents

Announcement(s)